RT Book, Section
A1 Kaneko, Tsuyoshi
A1 Yammine, Maroun
A1 Loberman, Dan
A1 Aranki, Sary
A2 Cohn, Lawrence H.
A2 Adams, David H.
SR Print(0)
ID 1144165653
T1 Mitral Valve Replacement
T2 Cardiac Surgery in the Adult, 5e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071844871
LK accesssurgery.mhmedical.com/content.aspx?aid=1144165653
RD 2024/04/20
AB This  chapter  discusses  the  surgical  indications,  operative  techniques,  and  early  and  late  follow-up  after  implantation  of  mechanical  and  bioprosthetic  mitral  valve  devices.  The  valves  that  are  discussed  are  those  that  are  currently  (2015)  approved  by  the  Food  and  Drug  Administration  (FDA).  Figure  42-1  shows  the  former  and  current  FDA-approved  prosthetic  mechanical  mitral  valve  devices,  including  the  Starr-Edwards  ball-and-cage  valve  (historical  relevance  only),  the  Omnicarbon  tilting-disk  valve,  the  Medtronic  Hall  tilting-disk  valve,  the  St.  Jude  Medical  bileaflet  valve,  the  Carbomedics  bileaflet  valve,  the  ATS  bileaflet  valve,  and  the  On-X  bileaflet  valve.  The  FDA-approved  bioprosthetic  valve  devices  are  shown  in  Fig.  42-2  and  include  the  Hancock  II  porcine  valve,  the  Carpentier-Edwards  porcine  valve,  the  Carpentier-Edwards  pericardial  valve,  the  Mosaic  porcine  valve,  and  the  Biocor  porcine  valve.